ArticleMolecular cancer therapeutics2016

A Phase I Trial to Evaluate Antibody-Dependent Cellular Cytotoxicity of Cetuximab and Lenalidomide in Advanced Colorectal and Head and Neck Cancer.

Erin M Bertino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.